ModEx

ModEx (Modular Expression) is an innovative biotechnology company developing cutting-edge multi-specific antibody and protein therapeutics utilizing proprietary modular engineering platforms. By combining multiple therapeutic mechanisms into single, highly stable molecules, ModEx aims to transform treatments within oncology, infectious diseases, and complex immune disorders.
Purchase on Scientist.com